• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美敦力霍尔瓣膜假体的十年经验。对1104例患者的研究。

Ten-year experience with the Medtronic Hall valvular prosthesis. A study of 1,104 patients.

作者信息

Nitter-Hauge S, Abdelnoor M

机构信息

Medical Department B, Rikshospitalet, University of Oslo, Norway.

出版信息

Circulation. 1989 Sep;80(3 Pt 1):I43-8.

PMID:2766537
Abstract

The Medtronic Hall valvular prosthesis was introduced in 1977 and was used for the first time in Oslo in June of that year. We report here our 10-year experience with this prosthesis, based on studies of all 1,104 consecutive patients who were operated on from June 1977 to August 1987. There were 816 aortic (AVR), 187 mitral (MVR), and 101 combined mitral and aortic (double, DVR) valve replacements. Cumulative follow-up was 5,061 patient-years, with a mean follow-up of 4.6 years. Early mortality was 3.8% after AVR, 7.5% after MVR, and 10.0% after DVR. The probability of surviving 10 years after AVR was 72%; after MVR, 56%; and after DVR, 60%. Early and late survival reflected the patient's preoperative status and nonvalvular cardiac disease. Thromboembolism occurred at linearized rates of 1.3%, 1.3%, and 1.8%/yr after AVR, MVR, and DVR, respectively. There were five cases of valvular thrombosis, none fatal, resulting in a linearized rate of 0.1%, 0.1%, and 0.2%/yr after AVR, MVR, and DVR, respectively. There were no instances of structural failure. Morbidity from anticoagulant-related hemorrhage was 0.7%/yr, with seven fatal events, all of cerebral origin. The long-term experience with the Medtronic Hall valve indicates that, in addition to its previously demonstrated excellent hemodynamic performance, there are low risks of thromboembolism and thrombosis and no instances of primary structural failure.

摘要

美敦力Hall瓣膜假体于1977年推出,并于同年6月在奥斯陆首次使用。在此,我们报告基于对1977年6月至1987年8月连续接受手术的1104例患者的研究,使用该瓣膜假体的10年经验。其中有816例主动脉瓣置换术(AVR)、187例二尖瓣置换术(MVR)以及101例二尖瓣和主动脉瓣联合置换术(双瓣置换术,DVR)。累积随访时间为5061患者年,平均随访时间为4.6年。AVR术后早期死亡率为3.8%,MVR术后为7.5%,DVR术后为10.0%。AVR术后10年生存概率为72%;MVR术后为56%;DVR术后为60%。早期和晚期生存率反映了患者的术前状况和非瓣膜性心脏病。AVR、MVR和DVR术后血栓栓塞的线性发生率分别为每年1.3%、1.3%和1.8%。有5例瓣膜血栓形成,均非致命,AVR、MVR和DVR术后的线性发生率分别为每年0.1%、0.1%和0.2%。没有发生结构故障的情况。抗凝相关出血的发病率为每年0.7%,有7例致命事件,均源于脑部。美敦力Hall瓣膜的长期经验表明,除了其先前已证明的出色血流动力学性能外,血栓栓塞和血栓形成的风险较低,且没有原发性结构故障的情况。

相似文献

1
Ten-year experience with the Medtronic Hall valvular prosthesis. A study of 1,104 patients.美敦力霍尔瓣膜假体的十年经验。对1104例患者的研究。
Circulation. 1989 Sep;80(3 Pt 1):I43-8.
2
Fifteen-year experience with the medtronic-hall valve prosthesis. A follow-up study of 1104 consecutive patients.美敦力-霍尔人工心脏瓣膜假体的15年经验。对1104例连续患者的随访研究。
Circulation. 1996 Nov 1;94(9 Suppl):II105-8.
3
Clinical evaluation of the carbomedics prosthesis: experience at providence health system in Portland.卡波美迪克斯人工关节的临床评估:波特兰普罗维登斯健康系统的经验
J Heart Valve Dis. 2002 Nov;11(6):844-50.
4
A 5-year follow-up of the Medtronic-Hall valve: survival and thromboembolism.美敦力-霍尔瓣膜5年随访:生存率与血栓栓塞情况
Thorac Cardiovasc Surg. 1983 May;31 Spec 2:61-5. doi: 10.1055/s-2007-1022031.
5
Eighteen-year follow up after Hancock II bioprosthesis insertion.汉考克二代生物假体植入术后18年随访。
J Heart Valve Dis. 1999 Jan;8(1):16-24.
6
The Ultracor tilting disc heart valve prosthesis: a seven-year study.Ultracor倾斜盘式心脏瓣膜假体:一项为期七年的研究。
J Heart Valve Dis. 1998 Nov;7(6):647-54.
7
A 10-year experience with the Carbomedics cardiac prosthesis.使用Carbomedics心脏瓣膜假体的10年经验。
Ann Thorac Surg. 2005 Mar;79(3):784-9. doi: 10.1016/j.athoracsur.2004.08.067.
8
[Early and late results of St. Jude Medical prosthesis in aortic and mitral portion].[圣犹达医疗公司人工心脏瓣膜在主动脉和二尖瓣部位的早期及晚期效果]
Rinsho Kyobu Geka. 1989 Aug;9(4):374-80.
9
Evaluation of valve-related complications in patients with Sorin Bicarbon prosthesis: a seven-year experience.索林碳酸氢盐人工瓣膜患者瓣膜相关并发症的评估:七年经验
J Heart Valve Dis. 2001 Nov;10(6):795-801.
10
Eleven-year single-center experience with the ATS Open Pivot Bileaflet heart valve.关于ATS开放枢轴双叶心脏瓣膜的11年单中心经验。
Ann Thorac Surg. 2006 Sep;82(3):847-52. doi: 10.1016/j.athoracsur.2006.04.042.